2-Bromopropionyl chloride

We are 2-Bromopropionyl chloride CAS:7148-74-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-Bromopropionyl chloride
CAS.NO:7148-74-5
Synonyms:Propanoyl chloride, 2-bromo-
Molecular Formula:C3H4BrClO
Molecular Weight:171.42000
 
Physical and Chemical Properties:
Density:1.7;
Melting point:-52oC;
Boiling point:131-133oC;
Flash point:125oF;
Index of Refraction:1.477;
 
Specification:
Appearance:Clear,colourless to dark yellow liquid
Purity(GC):≥98.5%
Moisture:≤0.1%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Synthesis:2-Bromopropionyl chloride is prepared by the reaction of (2S)-2-bromopropanoic acid and Thionyl chloride
Application:Applicationd as pharmaceutical intermediates, organic synthesis.

2-Bromopropionyl chloride


Related News: In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.Difluoromethylthioacetic acid The primary endpoint of INSPIRE is overall survival. The trial continued beyond the pre-specified interim analysis and is nearing its conclusion.2-fluoro-5-formilbenzonitrilo CAS:218301-22-5 The primary endpoint of INSPIRE is overall survival. The trial continued beyond the pre-specified interim analysis and is nearing its conclusion.2-bromo-4-chlorobenzaldehyde ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy.ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy.

Related Products
Product Name
6-Chloro-3-methyluracil View Details
Cytidine-5′-diphosphate disodium salt View Details
4-[(4-fluoroanilino)methylidene]cyclohexa-2,5-dien-1-one View Details
tert-butyl (3R,4S)-3-(1-ethoxyethoxy)-2-oxo-4-phenylazetidine-1-carboxylate manufacturer 4-Hydrazinobenzene-1-sulfonamide hydrochloride manufacturer Pentane-1,5-diyl diacrylate manufacturer Methyl (11Z)-11-icosenoate manufacturer 4-(methylamino)-3-nitrobenzoyl chloride manufacturer